美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

西北生物療法

0.2130

-0.0061-2.78%

成交量：329.93萬

成交額：71.53萬

市值：3.28億

市盈率：-3.27

高：0.2330

開：0.2150

低：0.2062

收：0.2191

52周最高：0.4788

52周最低：0.1685

股本：15.41億

流通股本：15.41億

量比：1.07

換手率：0.21%

股息：- -

股息率：- -

每股收益(TTM):-0.0652

每股收益(LYR):-0.0575

淨資產收益率：276.45%

總資產收益率：-135.39%

市淨率：-3.02

市盈率(LYR):-3.70

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

西北生物療法

交易所：

OTCQB

成立時間：

1996

員工人數：

25

公司地址：

4800 Montgomery Lane,Suite 800,Bethesda,Maryland,United States

官網：

http://www.nwbio.com

郵編：

20814

電話：

傳真：

- -

簡介：

Northwest Biotherapeutics, Inc.是一家成立於1996年3月18日，還處於發展階段的生物技術公司。公司同時成立於美國和歐洲（世界上最大的兩個醫療市場），並且還為在德國進行的臨床試驗做準備工作。公司專註於開發比目前治療方法更有效的，治療癌症的免疫治療產品。該產品還無須進行有毒副作用的化療。並且，該公司因為其專有的批量生產技術，擁有成本效益優良的基礎。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NWBO/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NWBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","market":"US","secType":"STK","nameCN":"西北生物療法","latestPrice":0.213,"timestamp":1774036800000,"preClose":0.2191,"halted":0,"volume":3299258,"delay":15,"changeRate":-0.027841168416248264,"floatShares":1541000000,"shares":1541000000,"eps":-0.065174,"marketStatus":"盤後交易","change":-0.0061,"latestTime":"03-20 16:00:00 EDT 延時","open":0.215,"high":0.233,"low":0.2062,"amount":715319.1991500005,"amplitude":0.122319,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.065174,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774051200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.2191,"volumeRatio":1.072001},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","floatShares":1541000000,"roa":"-135.39%","roe":"276.45%","lyrEps":-0.057517,"volumeRatio":1.072001,"shares":1541000000,"dividePrice":0,"high":0.233,"amplitude":0.122319,"preClose":0.2191,"low":0.2062,"week52Low":0.16845,"pbRate":"-3.02","psRate":"350.30","week52High":0.4788,"institutionHeld":0.001,"latestPrice":0.213,"eps":-0.065174,"divideRate":0,"volume":3299258,"delay":15,"ttmEps":-0.065174,"open":0.215,"prevYearClose":0.22875,"prevWeekClose":0.2245,"prevMonthClose":0.2259,"prevQuarterClose":0.2288,"fiveDayClose":0.2245,"twentyDayClose":0.24,"sixtyDayClose":0.2568},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NWBO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-10","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-05","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1709614800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1699506000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NWBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NWBO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1342115,"yearFounded":1996,"employeeNum":25,"address":"4800 Montgomery Lane,Suite 800,Bethesda,Maryland,United States","zipCode":"20814","officePhone":"240 497 9024"},"stockCompanyDetail":{"websiteUrl":"http://www.nwbio.com","stockEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":-0.1296},{"period":"3month","weight":-0.0208},{"period":"6month","weight":-0.2047},{"period":"1year","weight":0.2368},{"period":"ytd","weight":0.1436}],"description":"Northwest Biotherapeutics, Inc.是一家成立於1996年3月18日，還處於發展階段的生物技術公司。公司同時成立於美國和歐洲（世界上最大的兩個醫療市場），並且還為在德國進行的臨床試驗做準備工作。公司專註於開發比目前治療方法更有效的，治療癌症的免疫治療產品。該產品還無須進行有毒副作用的化療。並且，該公司因為其專有的批量生產技術，擁有成本效益優良的基礎。","exchange":"OTCQB","name":"西北生物療法","nameEN":"Northwest Biotherapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NWBO\",market:\"US\",,,undefined,":null}}